The effects of toxoplasmosis infection on the levels of IL-18 and anti-ds-DNA antibodies in SLE patients
Keywords:
toxoplasma gondii, systemic lupus erythematosus, Interleukin-18, anti-ds DNA antibodiesAbstract
The present study was set to demonstrate the prevalence of toxoplasmosis infection and its effects on patients with systemic lupus erythematosus (SLE) through determining their serum levels of anti-dsDNA and IL-18 antibodies. For this purpose, the sera from 132 SLE and/or toxoplasmosis patients and 30 healthy women, were collected. The study sample was divided into four groups of SLE, toxoplasmosis, SLE coinfected with toxoplasmosis, and healthy control. Anti-Toxoplasma IgG antibodies were examined for all the samples using ELISA kit. The results showed a high mean level of anti-Toxoplasma IgG among SLE patients coinfected with toxoplasmosis (104.8792±12.31585pg/ml) in comparison to that in toxoplasmosis patients (91.1705±12.57746pg/ml). However, the mean value of anti-dsDNA antibodies showed significant (P≤0.01) elevation in SLE patients and SLE patients coinfected with toxoplasmosis (71.2134±9.22131pg/ml and 72.3699±9.67917 pg/ml, respectively), compared to those infected with toxoplasmosis only and healthy control. Furthermore, the IL-18 mean value in the sera of the studied patients showed significant (P≤0.01) elevation (418.4000±43.18072pg/ml) in SLE patients with toxoplasmosis in comparison to SLE patients (354.4400±35.29257pg/ml). The present investigation suggests that the levels of anti-Toxoplasma IgG antibodies seem to increase in patients with SLE.
Downloads
References
Mikaeel, F. and A. Al-Saeed, SEROLOGICAL AND MOLECULAR DIAGNOSIS OF TOXOPLASMA GONDII AMONG EWES AND HORSES IN DUHOK PROVINCE-IRAQ. The Iraqi Journal of Agricultural Science, 2020. 51(4): p. 1212-1219.
Prandota, J., Possible critical role of latent chronic Toxoplasma gondii infection in triggering, development and persistence of autoimmune diseases. International Journal of Neurology Research, 2018. 4(1): p. 379-463.
Abamecha, F. and H. Awel, Seroprevalence and risk factors of Toxoplasma gondii infection in pregnant women following antenatal care at Mizan Aman General Hospital, Bench Maji Zone (BMZ), Ethiopia. BMC infectious diseases, 2016. 16(1): p. 1-8.
Hosseininejad, Z., et al., Toxoplasmosis seroprevalence in rheumatoid arthritis patients: a systematic review and meta-analysis. PLoS neglected tropical diseases, 2018. 12(6): p. e0006545.
Aldabagh, M.A.-G.H., et al., Immune profile in aborted Iraqi women with toxoplasmosis. Medical Journal of Babylon, 2018. 15(1): p. 48.
Jung, J.-Y. and C.-H. Suh, Infection in systemic lupus erythematosus, similarities, and differences with lupus flare. The Korean journal of internal medicine, 2017. 32(3): p. 429.
Hagberg, N. and L. Rönnblom, Systemic lupus erythematosus–a disease with a dysregulated type I interferon system. Scandinavian journal of immunology, 2015. 82(3): p. 199-207.
Ohl, K. and K. Tenbrock, Regulatory T cells in systemic lupus erythematosus. European journal of immunology, 2015. 45(2): p. 344-355.
Grammatikos, A.P. and G.C. Tsokos, Immunodeficiency and autoimmunity: lessons from systemic lupus erythematosus. Trends in molecular medicine, 2012. 18(2): p. 101-108.
Xiang, M., et al., Correlation between circulating interleukin-18 level and systemic lupus erythematosus: A meta-analysis. Scientific reports, 2021. 11(1): p. 1-9.
Cigni, A., et al., Interleukin 1, interleukin 6, interleukin 10, and tumor necrosis factor α in active and quiescent systemic lupus erythematosus. Journal of Investigative Medicine, 2014. 62(5): p. 825-829.
Xu, W.-D., H.-F. Pan, and D.-Q. Ye, Association of interleukin-18 and systemic lupus erythematosus. Rheumatology international, 2013. 33(12): p. 3055-3057.
Giles, B.M. and S.A. Boackle, Linking complement and anti-dsDNA antibodies in the pathogenesis of systemic lupus erythematosus. Immunologic research, 2013. 55(1): p. 10-21.
Wang, X. and Y. Xia, Anti-double stranded DNA antibodies: origin, pathogenicity, and targeted therapies. Frontiers in immunology, 2019. 10: p. 1667.
Siddiqui, N., et al., IgG avidity antibodies against Toxoplasma gondii in high risk females of reproductive age group in India. The Korean Journal of Parasitology, 2014. 52(5): p. 487.
Al-Jebouri, M., M. Al-Janabi, and H. Ismail, The prevalence of toxoplasmosis among female patients in Al-Hawija and Al-Baiji Districts in Iraq. 2013.
Al-Tufaili, R.A.N., Evaluation of commercial Linked immune-sorbentassay (ELISA) for detecting sero-prevalence of Toxoplasmagondii antibodies in Iraqi women. 2020.
Mahmoud, Z.H., N.F.A. Kareem, and A.A.A. Kareem, Effect of solvents on size of copper oxide nanoparticles fabricated using photolysis method. Asian Journal of chemistry, 2018. 30(1): p. 223-225.
Alkhanak, Y.R., S.N. Alwachi, and K.H. Zghair, The Effect of Toxoplasmosis Infection on Interleukin-12Level During Human Maturity in Baghdad Province. Iraqi Journal of Science, 2015. 56(1B): p. 356-360.
Jafari, A.A., et al., Parasite-based interventions in systemic lupus erythematosus (SLE): A systematic review. Autoimmunity Reviews, 2021. 20(10): p. 102896.
Fischer, S., et al., Toxoplasma gondii: bystander or cofactor in rheumatoid arthritis. Immunologic research, 2013. 56(2): p. 287-292.
Hamza, H., et al., Toxoplasma gondii seropositivity in renal patients: rate, pattern, predictors and related morbidity. Journal of the Egyptian Society of Parasitology, 2015. 45(1): p. 7-15.
Bizzaro, N., et al., Are anti-nucleosome antibodies a better diagnostic marker than anti-dsDNA antibodies for systemic lupus erythematosus? A systematic review and a study of metanalysis. Autoimmunity reviews, 2012. 12(2): p. 97-106.
Dong, Y., et al., The deposition of anti-DNA IgG contributes to the development of cutaneous lupus erythematosus. Immunology Letters, 2017. 191: p. 1-9.
Patiño-Trives, A.M., et al., Anti-dsDNA Antibodies Increase the Cardiovascular Risk in Systemic Lupus Erythematosus Promoting a Distinctive Immune and Vascular Activation. Arteriosclerosis, thrombosis, and vascular biology, 2021. 41(9): p. 2417-2430.
Orme, M.E., et al., Systematic review of anti-dsDNA testing for systemic lupus erythematosus: a meta-analysis of the diagnostic test specificity of an anti-dsDNA fluorescence enzyme immunoassay. Autoimmunity Reviews, 2021. 20(11): p. 102943.
Chen, M., et al., Toxoplasma gondii infection inhibits the development of lupus‐like syndrome in autoimmune (New Zealand Black× New Zealand White) F1 mice. International immunology, 2004. 16(7): p. 937-946.
Novick, D., et al., High circulating levels of free interleukin-18 in patients with active SLE in the presence of elevated levels of interleukin-18 binding protein. Journal of autoimmunity, 2010. 34(2): p. 121-126.
Aghdashi, M., S. Aribi, and S. Salami, Serum levels of IL-18 in Iranian females with systemic lupus erythematosus. Medical Archives, 2013. 67(4): p. 237.
Song, G.G., et al., Association between interleukin-18 polymorphisms and systemic lupus erythematosus: a meta-analysis. Molecular biology reports, 2013. 40(3): p. 2581-2587.
Mohsen, M.A., et al., Serum interleukin-18 levels in patients with systemic lupus erythematosus: relation with disease activity and lupus nephritis. The Egyptian Rheumatologist, 2013. 35(1): p. 45-51.
Yasuda, K., K. Nakanishi, and H. Tsutsui, Interleukin-18 in health and disease. International journal of molecular sciences, 2019. 20(3): p. 649.
Cai, G., R. Kastelein, and C.A. Hunter, Interleukin-18 (IL-18) enhances innate IL-12-mediated resistance to Toxoplasma gondii. Infection and immunity, 2000. 68(12): p. 6932-6938.
Vossenkämper, A., et al., Both IL‐12 and IL‐18 contribute to small intestinal Th1‐type immunopathology following oral infection with Toxoplasma gondii, but IL‐12 is dominant over IL‐18 in parasite control. European journal of immunology, 2004. 34(11): p. 3197-3207.
Kustina, K.T., Dewi, G.A.A.O., Prena, G.D., Suryasa, W. (2019). Branchless banking, third-party funds, and profitability evidence reference to banking sector in indonesia. Journal of Advanced Research in Dynamical and Control Systems, 11(2), 290-299.
Nyandra, M., Kartiko, B.H., Susanto, P.C., Supriyati, A., Suryasa, W. (2018). Education and training improve quality of life and decrease depression score in elderly population. Eurasian Journal of Analytical Chemistry, 13(2), 371-377.
Aprianto, D. R., Parenrengi, M. A., Utomo, B., Fauzi, A. A., & Subagyo, E. A. (2022). Autograft and implant cranioplasty in pediatric patients. International Journal of Health & Medical Sciences, 5(1), 129-136. https://doi.org/10.21744/ijhms.v5n1.1852
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
